Case report of bilateral inflammatory breast cancer

Y A Masannat; M Peter; P Turton; A M Shaaban

doi:10.1111/j.1365-2354.2009.01075.x

Case report of bilateral inflammatory breast cancer

Y A Masannat, M Peter, P Turton, A M Shaaban

Health Services Research Unit (HSRU)

Leeds General Infirmary

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Inflammatory breast cancer (IBC) is a rare entity that makes up 1-3% of breast cancers. As the diagnosis of IBC is mainly clinical, for the inexperienced the clinical appearance can mimic mastitis leading to diagnostic delay and it is often associated with a poor prognosis. Very few cases of bilateral IBC are reported in the literature, all of which have been synchronous. We report an unusual case of bilateral metachronous IBC each with complete clinico-pathological response after treatment with neoadjuvant chemotherapy and surgery on both occasions.

Original language	English
Pages (from-to)	558-60
Number of pages	3
Journal	European Journal of Cancer Care
Volume	19
Issue number	4
Early online date	15 Jun 2010
DOIs	https://doi.org/10.1111/j.1365-2354.2009.01075.x
Publication status	Published - Jul 2010

Keywords

Antineoplastic Agents/therapeutic use
Breast Neoplasms/drug therapy
Female
Humans
Inflammatory Breast Neoplasms/drug therapy
Middle Aged
Neoadjuvant Therapy
Treatment Outcome

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1365-2354.2009.01075.x

Cite this

@article{6ea7eaf72d464943875b56707a7bd6e4,

title = "Case report of bilateral inflammatory breast cancer",

abstract = "Inflammatory breast cancer (IBC) is a rare entity that makes up 1-3% of breast cancers. As the diagnosis of IBC is mainly clinical, for the inexperienced the clinical appearance can mimic mastitis leading to diagnostic delay and it is often associated with a poor prognosis. Very few cases of bilateral IBC are reported in the literature, all of which have been synchronous. We report an unusual case of bilateral metachronous IBC each with complete clinico-pathological response after treatment with neoadjuvant chemotherapy and surgery on both occasions.",

keywords = "Antineoplastic Agents/therapeutic use, Breast Neoplasms/drug therapy, Female, Humans, Inflammatory Breast Neoplasms/drug therapy, Middle Aged, Neoadjuvant Therapy, Treatment Outcome",

author = "Masannat, {Y A} and M Peter and P Turton and Shaaban, {A M}",

year = "2010",

month = jul,

doi = "10.1111/j.1365-2354.2009.01075.x",

language = "English",

volume = "19",

pages = "558--60",

journal = "European Journal of Cancer Care",

issn = "0961-5423",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - Case report of bilateral inflammatory breast cancer

AU - Masannat, Y A

AU - Peter, M

AU - Turton, P

AU - Shaaban, A M

PY - 2010/7

Y1 - 2010/7

N2 - Inflammatory breast cancer (IBC) is a rare entity that makes up 1-3% of breast cancers. As the diagnosis of IBC is mainly clinical, for the inexperienced the clinical appearance can mimic mastitis leading to diagnostic delay and it is often associated with a poor prognosis. Very few cases of bilateral IBC are reported in the literature, all of which have been synchronous. We report an unusual case of bilateral metachronous IBC each with complete clinico-pathological response after treatment with neoadjuvant chemotherapy and surgery on both occasions.

AB - Inflammatory breast cancer (IBC) is a rare entity that makes up 1-3% of breast cancers. As the diagnosis of IBC is mainly clinical, for the inexperienced the clinical appearance can mimic mastitis leading to diagnostic delay and it is often associated with a poor prognosis. Very few cases of bilateral IBC are reported in the literature, all of which have been synchronous. We report an unusual case of bilateral metachronous IBC each with complete clinico-pathological response after treatment with neoadjuvant chemotherapy and surgery on both occasions.

KW - Antineoplastic Agents/therapeutic use

KW - Breast Neoplasms/drug therapy

KW - Female

KW - Humans

KW - Inflammatory Breast Neoplasms/drug therapy

KW - Middle Aged

KW - Neoadjuvant Therapy

KW - Treatment Outcome

U2 - 10.1111/j.1365-2354.2009.01075.x

DO - 10.1111/j.1365-2354.2009.01075.x

M3 - Article

C2 - 19708943

SN - 0961-5423

VL - 19

SP - 558

EP - 560

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

IS - 4

ER -

Case report of bilateral inflammatory breast cancer

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this